Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Germany's Schmidt sings praises of DMPs (Disease-Management -Programmes) after QA report

This article was originally published in Clinica

Executive Summary

Germany's Disease-Management-Programmes have become a firm part of healthcare provision in Germany. So said health minister Ulla Schmidt, on the publication this week of the first quality assessment (QA) report of the DMPs, which have been established now for two-and-a-half years. The DMPs are "good for chronic patients and for doctors", who view them as providing guaranteed, high-quality treatment on an economic basis, she said.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT054260

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel